There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

The surge in THC edibles and their accidental ingestion by children has sparked an urgent concern. On April 14, news of a ...